scholarly article | Q13442814 |
P50 | author | Adam A Witney | Q42128234 |
Philip Butcher | Q61996782 | ||
P2093 | author name string | Marcus J Pond | |
Achyuta V Nori | |||
Syed Tariq Sadiq | |||
Rose C Lopeman | |||
P2860 | cites work | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic | Q21133562 |
Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis | Q24605678 | ||
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models | Q27860746 | ||
Nongonococcal urethritis: new views through the prism of modern molecular microbiology | Q31154685 | ||
Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system | Q33355815 | ||
Sexually transmitted diseases treatment guidelines, 2010. | Q34155140 | ||
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis | Q34245136 | ||
Sequence-based typing of Mycoplasma genitalium reveals sexual transmission | Q34719702 | ||
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial | Q35019879 | ||
Mycoplasma genitalium: should we treat and how? | Q35542157 | ||
Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases | Q35608986 | ||
Azithromycin failure in Mycoplasma genitalium urethritis | Q35792616 | ||
Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic | Q36240112 | ||
Performance of the GeneXpert CT/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima Samples | Q36414075 | ||
Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial | Q36656274 | ||
Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium | Q36757682 | ||
Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium | Q36971250 | ||
Comparison of a TaqMan-based real-time polymerase chain reaction with conventional tests for the detection of Trichomonas vaginalis | Q37006098 | ||
Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium | Q37191589 | ||
Urethritis/cervicitis pathogen prevalence and associated risk factors among asymptomatic HIV-infected patients in South Africa | Q37848635 | ||
The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. | Q37849110 | ||
Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens. | Q37849678 | ||
Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing | Q38053068 | ||
Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins | Q45174187 | ||
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance | Q46260038 | ||
Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial | Q46954398 | ||
Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. | Q54359754 | ||
gyrB and parE mutations in urinary Mycoplasma genitalium DNA from men with non-gonococcal urethritis | Q54411006 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibiotic resistance | Q380775 |
urethritis | Q1122485 | ||
Mycoplasma genitalium | Q1930909 | ||
P304 | page(s) | 631-637 | |
P577 | publication date | 2013-11-26 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options | |
P478 | volume | 58 |
Q64110419 | "It's not a time spent issue, it's a 'what have you spent your time doing?' issue…" A qualitative study of UK patient opinions and expectations for implementation of Point of Care Tests for sexually transmitted infections and antimicrobial resistan |
Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
Q37836494 | 2016 European guideline on the management of non-gonococcal urethritis |
Q47553525 | 2016 United Kingdom national guideline on the sexual health care of men who have sex with men. |
Q36933110 | A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens. |
Q37280597 | A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples. |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q35934198 | Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design |
Q99241152 | Azithromycin combined with doxycycline in non-gonococcal urethritis |
Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
Q37382490 | Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment |
Q30235030 | Chlamydia trachomatis Genital Infections |
Q21284727 | Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health |
Q56888473 | Clinical and sexual risk correlates of in urban pregnant and non-pregnant young women: cross-sectional outcomes using the baseline data from the Women's BioHealth Study |
Q29247953 | Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021. |
Q37844334 | Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts |
Q43087983 | Diagnostic and resistance testing for Mycoplasma genitalium: what will it take? |
Q37713726 | Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis |
Q35673469 | Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan |
Q38646438 | Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections |
Q42339724 | Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France |
Q40099689 | French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays. |
Q37835821 | Gardnerella vaginalis and Mollicute detection in rectal swabs from men who have sex with men. |
Q90135297 | HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique |
Q40917407 | High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. |
Q40346692 | High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands |
Q41521589 | Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. |
Q93077104 | Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection |
Q33597030 | Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium |
Q94601429 | Is Non-Chlamydial Non-Gonococcal Urethritis Associated with Significant Clinical Complications in Men? A Systematic Review |
Q37839814 | Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands |
Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
Q48537471 | Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. |
Q64239107 | Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014 |
Q41583528 | Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens |
Q92768481 | Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017 |
Q59799969 | Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q92016767 | Mollicutes antibiotic resistance profile and presence of genital abnormalities in couples attending an infertility clinic |
Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
Q89444103 | Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama |
Q37218590 | Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States |
Q94450769 | Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates |
Q36585646 | Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance |
Q64111407 | Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance |
Q27021073 | Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
Q40071934 | Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment |
Q38609857 | New Horizons in Mycoplasma genitalium Treatment |
Q35550723 | Performance evaluation of automated urine microscopy as a rapid, non-invasive approach for the diagnosis of non-gonococcal urethritis |
Q53691269 | Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study. |
Q33562762 | Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia |
Q97075329 | Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis |
Q42212384 | Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. |
Q38233471 | Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones |
Q57054894 | Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations |
Q41597319 | Structural characterization of the NAP; the major adhesion complex of the human pathogen Mycoplasma genitalium. |
Q41046965 | Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women |
Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
Q64098896 | Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against Species Clinical Isolates and Type Strains |
Q91944412 | Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium |
Search more.